Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin for Neuroprotection in Elderly Cardiac Surgery Patients

NCT01561378 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT01561378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01561378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin for Neuroprotection in Elderly Cardiac Surgery Patients
Lead sponsor
Albert Einstein College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
October 31, 2014
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative cognitive decline, post-operative delirium